Nanoencapsulated Doxorubicin Prevents Mucositis Development in Mice

• 主要な著者: Cristiane M. Pinto (著者), Laila S. Horta (著者), Amanda P. Soares (著者), Bárbara A. Carvalho (著者), Enio Ferreira (著者), Eduardo B. Lages (著者), Lucas A. M. Ferreira (著者), André A. G. Faraco (著者), Helton C. Santiago (著者), Gisele A. C. Goulart (著者)
• フォーマット: 図書
• 出版事項: MDPI AG, 2021-07-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Doxorubicin (DOX), a chemotherapy drug successfully used in the therapy of various types of cancer, is currently associated with the mucositis development, an inflammation that can cause ulcerative lesions in the mucosa of the gastrointestinal tract, abdominal pain and secondary infections. To incre...